Anti-RNF130 monoclonal antibody

Pre-made anti-RNF130 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RNF130/RNF130 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1505-Ab-1/ GM-Tg-hg-IP1505-Ab-2Anti-Human RNF130 monoclonal antibodyHuman
GM-Tg-rg-IP1505-Ab-1/ GM-Tg-rg-IP1505-Ab-2Anti-Rat RNF130 monoclonal antibodyRat
GM-Tg-mg-IP1505-Ab-1/ GM-Tg-mg-IP1505-Ab-2Anti-Mouse RNF130 monoclonal antibodyMouse
GM-Tg-cynog-IP1505-Ab-1/ GM-Tg-cynog-IP1505-Ab-2Anti-Cynomolgus/ Rhesus macaque RNF130 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1505-Ab-1/ GM-Tg-felg-IP1505-Ab-2Anti-Feline RNF130 monoclonal antibodyFeline
GM-Tg-cang-IP1505-Ab-1/ GM-Tg-cang-IP1505-Ab-2Anti-Canine RNF130 monoclonal antibodyCanine
GM-Tg-bovg-IP1505-Ab-1/ GM-Tg-bovg-IP1505-Ab-2Anti-Bovine RNF130 monoclonal antibodyBovine
GM-Tg-equg-IP1505-Ab-1/ GM-Tg-equg-IP1505-Ab-2Anti-Equine RNF130 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1505-Ab-1/ GM-Tg-hg-IP1505-Ab-2; GM-Tg-rg-IP1505-Ab-1/ GM-Tg-rg-IP1505-Ab-2;
GM-Tg-mg-IP1505-Ab-1/ GM-Tg-mg-IP1505-Ab-2; GM-Tg-cynog-IP1505-Ab-1/ GM-Tg-cynog-IP1505-Ab-2;
GM-Tg-felg-IP1505-Ab-1/ GM-Tg-felg-IP1505-Ab-2; GM-Tg-cang-IP1505-Ab-1/ GM-Tg-cang-IP1505-Ab-2;
GM-Tg-bovg-IP1505-Ab-1/ GM-Tg-bovg-IP1505-Ab-2; GM-Tg-equg-IP1505-Ab-1/ GM-Tg-equg-IP1505-Ab-2
Products NameAnti-RNF130 monoclonal antibody
Formatmab
Target NameRNF130
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RNF130 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1505-Ag-1Recombinant multi-species GOLI/ RNF130/ G1RZFP protein
    ORF Viral VectorpGMLPm003395mouse Rnf130 Lentivirus plasmid
    ORF Viral VectorvGMLPm003395mouse Rnf130 Lentivirus particle


    Target information

    Target IDGM-IP1505
    Target NameRNF130
    Gene ID55819,59044,652955,715356,474651,101085174,525735,100067162
    Gene Symbol and Synonyms2510042A13Rik,G1RP,G1RZFP,GOLIATH,GP,RNF130
    Uniprot AccessionQ86XS8,Q6Y290
    Uniprot Entry NameGOLI_HUMAN,GOLI_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000113269
    Target ClassificationN/A

    The target: RNF130, gene name: RNF130, also named as G1RZFP, GOLIATH, GP. The protein encoded by this gene contains a RING finger motif and is similar to g1, a Drosophila zinc-finger protein that is expressed in mesoderm and involved in embryonic development. The expression of the mouse counterpart was found to be upregulated in myeloblastic cells following IL3 deprivation, suggesting that this gene may regulate growth factor withdrawal-induced apoptosis of myeloid precursor cells. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.